In this community, professionals share information regarding the clinical, programmatic and community-oriented aspects of early diagnosis, treatment and prevention of multi-drug-resistant tuberculosis (MDR-TB). Members also use this forum to promote universal access to quality care for MDR-TB.

Community moderators

Masoud Dara, MD
WHO Europe - EURO
Christopher Gilpin, PhD, MPH
World Health Organization - WHO
Dylan Tierney
Brigham and Women's Hospital, Division of Global Health Equity

Recent discussion topics

Surrogate outcomes

By Tom Yates on 07 Feb, 2016 4 Replies

Hello, I'd like to draw people's attention to an important paper just published by Patrick Phillips and colleagues... The team reanalysed data from the REMoxTB trial, to assess how…

Fwd: FW: paper from STAT published in EID online

By Alaine Umubyeyi Nyaruhirira on 06 Feb, 2016 0 Replies

Dear all, Please see below link to an online publication from the DR STAT group on "Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis" *Alaine…

New TB Drugs: Balancing Regulation with Urgent Patient Needs

By Syed Rizwanuddin Ahmad on 04 Feb, 2016 0 Replies

Dear All, Two new publications* which I thought will be useful to folks in this forum. Best wishes, Rizwan Syed Rizwanuddin Ahmad, MD, MPH, FISPE, FCP Pharmacovigilance Consultant with a Special Interest to Strengthen National Medicines Regulatory…

New community members

User Photo

Sarah Ramer

Affiliated Organizations

International Mission Board

Work Locations


User Photo

Aneeka Kasmani

Affiliated Organizations

Civil hospital karachi

Work Locations


User Photo

Grace Hollands

Affiliated Organizations

Monash Health

Work Locations